Esma clarifies guidance on OTC derivatives in UCITS

20th July, 2016

Julie Aelbrecht

Firms will need to form their own valuation mechanism for OTC derivatives

Unlock this article with 1 month’s free and instant access to FOW Intelligence

Go beyond this article with 1 month’s free, no obligation access to FOW Intelligence — bringing you expert insights and analysis backed by our comprehensive volumes database. Everything you need to stay informed and make smarter decisions.

  1. • Actionable insights across global futures and options markets
  2. • Exclusive content, including breaking stories and interviews with market leaders
  3. • Daily newsletter delivering the day’s top stories straight to your inbox
  4. • Expert analysis to support smarter trading decisions
  5. • Extensive daily volumes database to monitor activity
  6. • Trusted by financial professionals for 40+ years
ABN AMRO
Bank of America
CBOE
Citi
Goldman Sachs
DRW Holdings
HSBC
J.P Morgan
Marex
Morgan Stanley
SGX
SocGen
Susquehanna
MUFG Investor Services
TP ICAP
ABN AMRO
Bank of America
CBOE
Citi
Goldman Sachs
DRW Holdings
HSBC
J.P Morgan
Marex
Morgan Stanley
SGX
SocGen
Susquehanna
MUFG Investor Services
TP ICAP
Already have an account?